Advantage Solutions (ADVWW) had the highest return on October 15 and this year by a mid-cap US stock, returning 42.1%.
| ASSET | % RETURN |
|---|---|
Advantage Solutions (ADVWW) | 42.11% |
Hims Hers Health (HIMS) | 13.49% |
Recursion Pharmaceuticals (RXRX) | 12.23% |
Nuscale Power (SMR) | 10.76% |
GRAIL, LLC (GRAL) | 9.64% |
Praxis Precision Medicines (PRAX) | 8.99% |
Arcus Biosciences (RCUS) | 8.54% |
Regencell Bioscience (RGC) | 7.82% |
Kymera Therapeutics (KYMR) | 7.52% |
Cogent Biosciences (COGT) | 7.39% |
Manchester United (MANU) | 7.29% |
New Oriental Education & Technology (EDU) | 7.15% |
Denali Therapeutics (DNLI) | 7.09% |
Sandisk (SNDK) | 7.09% |
Tarsus Pharmaceuticals (TARS) | 7.06% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 6.98% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 6.98% |
Viridian Therapeutics (VRDN) | 6.96% |
Adaptive Biotechnologies (ADPT) | 6.94% |
Celcuity LLC (CELC) | 6.74% |
ACADIA Pharmaceuticals (ACAD) | 6.52% |
Endeavour Silver (EXK) | 6.39% |
Arcellx (ACLX) | 6.23% |
Corcept Therapeutics (CORT) | 6.19% |
Soleno Therapeutics (SLNO) | 6.17% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
